Generic versions of anti-bacterials including Pfizer’s Zithromax (azithromycin), Abbott’s Biaxin (clarithromycin), Johnson & Johnson’s Levaquin (levofloxacin) and Bayer’s Avelox (moxifloxacin) have captured the ENT therapeutics market. These generic drugs …
